Literature DB >> 3930278

Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons.

P Brundin, O G Nilsson, F H Gage, A Björklund.   

Abstract

The survival and function of cross-species (mouse-to-rat) grafts of fetal mesencephalic dopamine (DA) neurons, implanted as a cell suspension in the striatum of rats with lesions of the mesostriatal DA system, have been studied in animals with and without immunosuppression induced by Cyclosporin A (CyA). At 6 weeks after grafting 3 out of 7 non-CyA treated animals showed some degree of graft survival and variable functional compensation. In those three animals an average of 92 DA neurons per graft was counted. In the grafted animals treated with daily CyA injections, all grafts survived and produced partial or complete functional compensation, and they had an average of 557 DA neurons per graft. It is concluded that intracerebral graft survival and function can be greatly improved by CyA treatment and that the immunological protection of neural transplants in the brain is only partial.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930278     DOI: 10.1007/bf00237035

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  17 in total

1.  Immunologic study of the brain as a privileged site.

Authors:  S Raju; J B Grogan
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

Review 2.  Immunologically privileged sites.

Authors:  C F Barker; R E Billingham
Journal:  Adv Immunol       Date:  1977       Impact factor: 3.543

3.  Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism.

Authors:  R H Schmidt; A Björklund; U Stenevi; S B Dunnett; F H Gage
Journal:  Acta Physiol Scand Suppl       Date:  1983

4.  Cross-species neural grafting in a rat model of Parkinson's disease.

Authors:  A Björklund; U Stenevi; S B Dunnett; F H Gage
Journal:  Nature       Date:  1982-08-12       Impact factor: 49.962

5.  [Homo- and heterospecific transplantation of embryonal tissue from the nervous system].

Authors:  A G Bragin; O S Vinogradova
Journal:  Biull Eksp Biol Med       Date:  1981-10

6.  The aluminum-formaldehyde (ALFA) histofluorescence method for improved visualization of catecholamines and indoleamines. I. A detailed account of the methodology for central nervous tissue using paraffin, cryostat or Vibratome sections.

Authors:  I Lorén; A Björklund; B Falck; O Lindvall
Journal:  J Neurosci Methods       Date:  1980-06       Impact factor: 2.390

7.  Cyclosporin A enhances the survivability of mouse cerebral cortex grafted into the third ventricle of rat brain.

Authors:  H Inoue; S Kohsaka; K Yoshida; M Ohtani; S Toya; Y Tsukada
Journal:  Neurosci Lett       Date:  1985-02-28       Impact factor: 3.046

8.  Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites.

Authors:  A Björklund; U Stenevi; R H Schmidt; S B Dunnett; F H Gage
Journal:  Acta Physiol Scand Suppl       Date:  1983

9.  Prolongation of cardiac xenograft survival in rats receiving cyclosporin A.

Authors:  W P Homan; K A Williams; J W Fabre; P R Millard; P J Morris
Journal:  Transplantation       Date:  1981-03       Impact factor: 4.939

10.  Embryonic neural transplants across a major histocompatibility barrier: survival and specificity of innervation.

Authors:  W C Low; P R Lewis; S T Terri
Journal:  Brain Res       Date:  1983-03-07       Impact factor: 3.252

View more
  31 in total

1.  A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease.

Authors:  R A Barker; E Ratcliffe; M McLaughlin; A Richards; S B Dunnett
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 2.  Transplantation of embryonic dopamine neurons: what we know from rats.

Authors:  S B Dunnett
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

Review 3.  Behavioural consequences of neural transplantation.

Authors:  S B Dunnett
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

4.  Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats.

Authors:  W M Duan; H Widner; P Brundin
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

5.  Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues.

Authors:  S B Dunnett; T D Hernandez; A Summerfield; G H Jones; G Arbuthnott
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

6.  Xenografting of fetal pig ventral mesencephalon corrects motor asymmetry in the rat model of Parkinson's disease.

Authors:  T K Huffaker; B D Boss; A S Morgan; N T Neff; R E Strecker; M S Spence; R Miao
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

7.  Histological signs of immune reactions against allogeneic solid fetal neural grafts in the mouse cerebellum depend on the MHC locus.

Authors:  I Date; K Kawamura; H Nakashima
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

8.  Chromaffin cell xenografts in the rat neocortex can produce antidepressive activity in the forced swimming test.

Authors:  C E Sortwell; G D Pappas; J Sagen
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

9.  Human fetal cerebellar and cortical tissue transplanted to the anterior eye chamber of athymic rats: electrophysiological and structural studies.

Authors:  P Bickford-Wimer; A C Granholm; M Bygdeman; B Hoffer; L Olson; A Seiger; I Strömberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

10.  Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease.

Authors:  P Brundin; O G Nilsson; R E Strecker; O Lindvall; B Astedt; A Björklund
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.